欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号BE/H/0182/001
药品名称Ambroxine
活性成分
    • ambroxol hydrochloride 20.0 mg
剂型Lozenge
上市许可持有人SCS Boehringer Ingelheim Comm.V 16 Aveneu Ariane B-1200 Bruxelles -> Procedure merged to BE/H/0181/001 !!
参考成员国 - 产品名称Belgium (BE)
Ambroxine 20 mg Lozenge
互认成员国 - 产品名称
    许可日期2012/03/09
    最近更新日期2016/07/15
    药物ATC编码
      • R02AD Anesthetics, local
    申请类型
    • TypeLevel1:Known Active Substance
    • TypeLevel2:Initial Application
    • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Non Prescription (including OTC)
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase